Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S John

Showing results (1091-1100 of 1,133) with videos related to

Pageof 114
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2024
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic MalignanciesEleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, et al.
The Lancet. Oncology|April 3, 2025
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trialToon Van Gorp, Kathleen N Moore, Gottfried E Konecny, et al.
Cancer Cell|September 5, 2017
LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and MetastasisShizhen Zhu, Xiaoling Zhang, Nina Weichert-Leahey, et al.
Research Square|June 12, 2026
A proteogenomic RNA processing mechanism drives sex differences in meningiomaDavid Raleigh, Martha Cady, Ayush Aggarwal, et al.
The New England Journal of Medicine|March 27, 2023
Pembrolizumab plus Chemotherapy in Advanced Endometrial CancerRamez N Eskander, Michael W Sill, Lindsey Beffa, et al.
Nature Medicine|March 5, 2025
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trialRamez N Eskander, Michael W Sill, Lindsey Beffa, et al.
European Heart Journal|August 8, 2024
KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndromeSahej Bains, Lucilla Giammarino, Saranda Nimani, et al.
BMC Musculoskeletal Disorders|June 11, 2011
A hinged external fixator for complex elbow dislocations: a multicenter prospective cohort studyNiels W L Schep, Jeroen De Haan, Gijs I T Iordens, et al.
Blood|January 28, 2021
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repairJithma P Abeykoon, Xiaosheng Wu, Kevin E Nowakowski, et al.
Nature|March 14, 2024
Blueprinting extendable nanomaterials with standardized protein blocksTimothy F Huddy, Yang Hsia, Ryan D Kibler, et al.
Pageof 114

Showing results (1091-1100 of 1,133) with videos related to

Sort By:
Pageof 114
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2024
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic MalignanciesEleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, et al.
The Lancet. Oncology|April 3, 2025
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trialToon Van Gorp, Kathleen N Moore, Gottfried E Konecny, et al.
Cancer Cell|September 5, 2017
LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and MetastasisShizhen Zhu, Xiaoling Zhang, Nina Weichert-Leahey, et al.
Research Square|June 12, 2026
A proteogenomic RNA processing mechanism drives sex differences in meningiomaDavid Raleigh, Martha Cady, Ayush Aggarwal, et al.
The New England Journal of Medicine|March 27, 2023
Pembrolizumab plus Chemotherapy in Advanced Endometrial CancerRamez N Eskander, Michael W Sill, Lindsey Beffa, et al.
Nature Medicine|March 5, 2025
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trialRamez N Eskander, Michael W Sill, Lindsey Beffa, et al.
European Heart Journal|August 8, 2024
KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndromeSahej Bains, Lucilla Giammarino, Saranda Nimani, et al.
BMC Musculoskeletal Disorders|June 11, 2011
A hinged external fixator for complex elbow dislocations: a multicenter prospective cohort studyNiels W L Schep, Jeroen De Haan, Gijs I T Iordens, et al.
Blood|January 28, 2021
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repairJithma P Abeykoon, Xiaosheng Wu, Kevin E Nowakowski, et al.
Nature|March 14, 2024
Blueprinting extendable nanomaterials with standardized protein blocksTimothy F Huddy, Yang Hsia, Ryan D Kibler, et al.
Pageof 114